Lantidra: Cell Therapy for Treatment of Type 1 Diabetes Mellitus DOI

Shital B. Bharambe,

Shailesh Jawarkar

Asian Journal of Pharmaceutical Research, Год журнала: 2024, Номер unknown, С. 331 - 335

Опубликована: Сен. 20, 2024

The more recent cell treatment for type 1 Diabetes is called lantidra. Lantidra has recently received approval to treat mellitus. first allogeneic (deceased donor) pancreatic islet therapy, lantidra (donislecel), was approved by the FDA Centre Biologics Evaluation and Research (CBER) on June 28, 2023. It intended adults with diabetes who, despite current management, do not achieve target glycosylated hemoglobin levels due recurrent episodes of severe hypoglycemia. editorial’s goal draw attention growing impact world’s health, discuss earlier attempts at transplant techniques, announces regulatory a revolutionary strategy beta infusion.

Язык: Английский

From stem cells to pancreatic β-cells: strategies, applications, and potential treatments for diabetes DOI
Xingrong Feng, Hongmei Zhang, Shanshan Yang

и другие.

Molecular and Cellular Biochemistry, Год журнала: 2024, Номер unknown

Опубликована: Апрель 20, 2024

Язык: Английский

Процитировано

4

Comprehensive Characterization of Bihormonal Cells and Endocrine Cell Lineages in Mammalian Pancreatic Islets DOI Creative Commons
Xin‐Xin Yu, Peng Peng, Yining Wang

и другие.

Advanced Science, Год журнала: 2025, Номер unknown

Опубликована: Май 29, 2025

Abstract Understanding the role and prevalence of bihormonal cells in pancreatic islets their potential β‐cell restoration is critical but remains ambiguous. Using genetically engineered mouse strains with specific fluorescent markers advanced imaging flow cytometry, it found that are exceedingly rare. Single‐cell RNA sequencing reveals Gcg + Ppy Ins closely resemble α‐cells or PP‐cells α‐cells, respectively, indicating they neither unique lineages nor transitional states. Dual‐recombinase lineage tracing further demonstrates embryonic resolve into monohormonal α‐cells. Applying these insights, scarcity diabetic models confirmed, suggesting a limited regeneration. By excluding influences, endocrine cell classification redefined human through gene coexpression network analysis, identifying distinct subtypes regulatory modules while uncovering species‐specific differences. Additionally, two δ‐cell subpopulations identified islets. Collectively, this study provides comprehensive characterization cells, refines taxonomy, underscores translational challenges modeling islet biology mice.

Язык: Английский

Процитировано

0

A systems view of cellular heterogeneity: Unlocking the “wheel of fate” DOI

Hourieh Movasat,

Enzo Giacopino,

Ali Shahdoost

и другие.

Cell Systems, Год журнала: 2025, Номер unknown, С. 101300 - 101300

Опубликована: Июнь 1, 2025

Язык: Английский

Процитировано

0

Exendin-4 affects calcium signalling predominantly during activation and activity of beta cell networks in acute mouse pancreas tissue slices DOI Creative Commons

Eva Paradiž Leitgeb,

Jasmina Kerčmar,

Lidija Križančić Bombek

и другие.

Frontiers in Endocrinology, Год журнала: 2024, Номер 14

Опубликована: Янв. 16, 2024

Tight control of beta cell stimulus-secretion coupling is crucial for maintaining homeostasis energy-rich nutrients. While glucose serves as a primary regulator this process, incretins augment function, partly by enhancing cytosolic [Ca 2+ ] dynamics. However, the details how precisely they affect recruitment during activation, their active time, and functional connectivity plateau activity, influence deactivation remain to be described. Performing multicellular Ca imaging in acute mouse pancreas tissue slices enabled us systematically assess effects GLP-1 receptor agonist exendin-4 (Ex-4) simultaneously many coupled cells with high resolution. In otherwise substimulatory glucose, Ex-4 was able recruit approximately quarter into an state. Costimulation stimulatory shortened activation delays accelerated More specifically, time increased faster, required reach half-maximal effectively halved presence Ex-4. Moreover, regularity IC oscillations increased, especially first part response. contrast, subsequent addition already did not significantly enhance activity. Network analyses further confirmed activity Ex-4, hub roles remaining rather stable both experiments Interestingly, demonstrated biphasic effect on deactivation, slightly prolonging at physiological concentrations shortening supraphysiological concentrations. sum, costimulation increases indicating that may, important extent, explained enhanced signals. During previous incretin stimulation does critically prolong cellular which corroborates low risk hypoglycemia.

Язык: Английский

Процитировано

3

Recent advancements in lipid nanoparticle technology for oral insulin delivery DOI Creative Commons

Induwara Welengodage,

Nuwanthi P. Katuwavila

University of Colombo Review, Год журнала: 2024, Номер 5(1), С. 130 - 144

Опубликована: Июнь 18, 2024

Nanotechnology is important in many industries, particularly drug delivery and administration. This technology has been used to create nanocarriers for enteral delivery. There are different types of including polysaccharide-based lipid-based nanocarriers. Lipid nanoparticles have recently developed loading administering insulin via the route treat diabetes mellitus. Insulin cannot be administered orally due its low bioavailability, extreme gastrointestinal conditions, instability. When loaded onto these nanocarriers, it increases stability, release pattern control, protects from conditions. review article aims discuss recent applications as well novel methods approaches oral using liposomes, solid lipid nanoparticles, nanostructured carriers.

Язык: Английский

Процитировано

2

An INSULIN and IAPP dual reporter enables tracking of functional maturation of stem cell-derived insulin producing cells DOI Creative Commons

Carmen Bayly,

Xiao-Qing Dai,

Cuilan Nian

и другие.

Molecular Metabolism, Год журнала: 2024, Номер 89, С. 102017 - 102017

Опубликована: Авг. 24, 2024

Human embryonic stem cell (hESC; SC)-derived pancreatic β cells can be used to study diabetes pathologies and develop replacement therapies. Although current differentiation protocols yield SCβ with varying degrees of maturation, these still differ from deceased donor human in several respects. We sought a reporter line that could dynamically track functional maturation.

Язык: Английский

Процитировано

0

Tipping-point transition from transient to persistent inflammation in pancreatic islets DOI Creative Commons

Thomas Holst-Hansen,

Pernille Yde, Mogens H. Jensen

и другие.

npj Systems Biology and Applications, Год журнала: 2024, Номер 10(1)

Опубликована: Сен. 12, 2024

Язык: Английский

Процитировано

0

Lantidra: Cell Therapy for Treatment of Type 1 Diabetes Mellitus DOI

Shital B. Bharambe,

Shailesh Jawarkar

Asian Journal of Pharmaceutical Research, Год журнала: 2024, Номер unknown, С. 331 - 335

Опубликована: Сен. 20, 2024

The more recent cell treatment for type 1 Diabetes is called lantidra. Lantidra has recently received approval to treat mellitus. first allogeneic (deceased donor) pancreatic islet therapy, lantidra (donislecel), was approved by the FDA Centre Biologics Evaluation and Research (CBER) on June 28, 2023. It intended adults with diabetes who, despite current management, do not achieve target glycosylated hemoglobin levels due recurrent episodes of severe hypoglycemia. editorial’s goal draw attention growing impact world’s health, discuss earlier attempts at transplant techniques, announces regulatory a revolutionary strategy beta infusion.

Язык: Английский

Процитировано

0